LEPU BIO-B(02157),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02157 LEPU BIO-B

Closed 03-02 16:08:34

4.170

-0.350

-7.74%

High4.400	Low4.150	Vol9.47M
Open4.390	D1 Closing4.520	Amplitude5.53%
Mkt Cap7.52B	Tradable Cap7.52B	Total Shares1.80B
T/O40.21M	T/O Rate0.53%	Tradable Shares1.80B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02157","market":"HK","secType":"STK","nameCN":"LEPU BIO-B","latestPrice":4.17,"timestamp":1772438914002,"preClose":4.52,"halted":0,"volume":9473000,"delay":0,"changeRate":-0.077433628318584,"floatShares":1804000000,"shares":1804000000,"eps":-0.243348,"marketStatus":"Closed","change":-0.35,"latestTime":"03-02 16:08:34","open":4.39,"high":4.4,"low":4.15,"amount":40207637,"amplitude":0.05531,"askPrice":4.17,"askSize":1000,"bidPrice":4.16,"bidSize":4000,"shortable":3,"etf":0,"ttmEps":-0.108,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1772501400000},"marketStatusCode":5,"adr":0,"listingDate":1645545600000,"exchange":"SEHK","adjPreClose":4.52,"openAndCloseTimeList":[[1772415000000,1772424000000],[1772427600000,1772438400000]],"volumeRatio":2.424498,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02157/tweets","defaultTab":"tweets","newsList":[{"id":"2610778026","title":"Lepu Biopharma Co., Ltd.'s (HKG:2157) Low P/S No Reason For Excitement","url":"https://stock-news.laohu8.com/highlight/detail?id=2610778026","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610778026?lang=en_us&edition=fundamental","pubTime":"2026-02-11 06:10","pubTimestamp":1770761455,"startTime":"0","endTime":"0","summary":"With a price-to-sales (or \"P/S\") ratio of 11.1x Lepu Biopharma Co., Ltd. ( HKG:2157 ) may be sending bullish signals at...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2157/lepu-biopharma-shares/news/lepu-biopharma-co-ltds-hkg2157-low-ps-no-reason-for-exciteme","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2157/lepu-biopharma-shares/news/lepu-biopharma-co-ltds-hkg2157-low-ps-no-reason-for-exciteme","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02157","91348","BK1161"],"gpt_icon":0},{"id":"1183757373","title":"Lepu Biopharma (02157) Releases Monthly Return Showing Unchanged Share Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=1183757373","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183757373?lang=en_us&edition=fundamental","pubTime":"2026-02-05 16:59","pubTimestamp":1770281942,"startTime":"0","endTime":"0","summary":"Lepu Biopharma Co., Ltd. (stock code: 02157) released its monthly return for the period ended 31 January 2026. The announcement indicates that the company’s authorized share capital remained at...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02157"],"gpt_icon":0},{"id":"1155519341","title":"HK Movers | Innovative Drug Stocks Jump With TYK Medicines up 14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1155519341","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155519341?lang=en_us&edition=fundamental","pubTime":"2026-01-07 09:57","pubTimestamp":1767751062,"startTime":"0","endTime":"0","summary":"Innovative drug stocks jumped in Hong Kong. TYK Medicines rose 14%; Lepu Biopharma rose 5%; Akeso and Hengrui Pharm rose 4%; HUTCHMED rose 3%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8cf272575aa59c1c9fc76dc7d5dd9c50","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926","01276","02157","02410","00013"],"gpt_icon":0},{"id":"2592897706","title":"Lepu Biopharma Announces Licensing Transaction Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2592897706","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592897706?lang=en_us&edition=fundamental","pubTime":"2025-12-18 19:13","pubTimestamp":1766056380,"startTime":"0","endTime":"0","summary":"Lepu Biopharma Co. Ltd. announced updates regarding its licensing transaction, confirming that all conditions precedent under the Intellectual Property Assignment and License Agreement have been fulfilled. The company has received the first tranche of the upfront payment from Excalipoint, and future royalty payments will be settled on a licensed product-by-licensed product basis following the first commercial sale of CTM012 or CTM013 pipeline products.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lepu Biopharma Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 18, 2025, and is solely responsible for the information c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL5R18db:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02157","BK1161"],"gpt_icon":0},{"id":"2592299979","title":"Lepu Biopharma Co. Ltd. held second extraordinary general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2592299979","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592299979?lang=en_us&edition=fundamental","pubTime":"2025-12-18 17:20","pubTimestamp":1766049659,"startTime":"0","endTime":"0","summary":"Lepu Biopharma Co. Ltd. held its second extraordinary general meeting on December 18, 2025. All proposals put forward at the meeting were approved by shareholders.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lepu Biopharma Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 18, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL8Y7T22:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02157"],"gpt_icon":0},{"id":"1165332973","title":"HKD 360 Billion Wiped Out! \"Consumer Trio\" Plunges Sharply","url":"https://stock-news.laohu8.com/highlight/detail?id=1165332973","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165332973?lang=en_us&edition=fundamental","pubTime":"2025-12-09 18:31","pubTimestamp":1765276316,"startTime":"0","endTime":"0","summary":"Hong Kong's consumer sector is facing a bitter winter. On December 9, the market-dubbed \"consumer trio\"—Pop Mart (09992.HK), Laopu Gold (06181.HK), and Mixue Group—extended their declines, dropping...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"472d09b75a94d186e11a32714224d521","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0327786744.USD","LU0359202008.SGD","LU0164865239.USD","LU0531971595.HKD","LU0359201885.HKD","LU2543165471.USD","LU0348767384.USD","02157","LU0823426480.USD","SGXZ62798434.SGD","SGXZ90724238.SGD","06181","LU0823426308.USD","SG9999001051.SGD","LU0359201612.USD","LU0211977185.USD","LU0593848301.USD","LU0611395673.USD","LU0572944931.SGD","LU0164880469.USD","SGXZ86797644.SGD","LU1770036033.HKD","LU0345775950.USD","LU0307460666.USD","BK1544","LU0871576103.HKD","LU0499858602.USD","LU0499858438.USD","LU1023057109.AUD","PMRTY","SINA","SG9999002950.SGD","LU0149721374.USD","LU0231483743.USD","LU0345776255.USD","BK1227","LU1481107354.HKD","LU0348766576.USD","SG9999001069.SGD","LU0588546209.SGD","LU0039217434.USD","BK1224","09992","IE0034224299.USD"],"gpt_icon":1},{"id":"2589822818","title":"Lepu Biopharma (SEHK:2157): Valuation Check After New GLP-1 CDMO Framework Deal With Lepu Medical","url":"https://stock-news.laohu8.com/highlight/detail?id=2589822818","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589822818?lang=en_us&edition=fundamental","pubTime":"2025-12-05 16:31","pubTimestamp":1764923516,"startTime":"0","endTime":"0","summary":"Lepu Biopharma (SEHK:2157) just signed a GLP-1 focused CDMO framework deal with related party Lepu Medical, a move that could turn spare manufacturing capacity into recurring cashflow and reshape how investors think about its pipeline driven story.\nSee our latest analysis for Lepu Biopharma.\nThe 1 day share price return of 3.0% to HK$5.76 comes after a volatile few months, with the 3 month share price return still down sharply. However, the year to date share price return and 1 year total...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2157/lepu-biopharma-shares/news/lepu-biopharma-sehk2157-valuation-check-after-new-glp-1-cdmo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2157/lepu-biopharma-shares/news/lepu-biopharma-sehk2157-valuation-check-after-new-glp-1-cdmo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4144","CDMO","GLP","02157","BK4139","BK4590","BK1161"],"gpt_icon":0},{"id":"1153046536","title":"Lepu Biopharma (02157) Reports Unchanged Share Capital for November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1153046536","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153046536?lang=en_us&edition=fundamental","pubTime":"2025-12-04 16:53","pubTimestamp":1764838419,"startTime":"0","endTime":"0","summary":"Lepu Biopharma Co., Ltd. (02157) submitted a monthly return for equity issuers, covering the period ended 30 November 2025. According to the announcement, the authorized and issued share capital...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02157"],"gpt_icon":0},{"id":"1134728285","title":"10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=1134728285","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134728285?lang=en_us&edition=fundamental","pubTime":"2025-12-03 19:38","pubTimestamp":1764761917,"startTime":"0","endTime":"0","summary":"On December 3, 2025, the \"10th Zhitong Capital Market Annual Conference & Listed Companies Awards Ceremony,\" jointly hosted by leading Hong Kong and U.S. stock information platform Zhitong Finance...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0175139822.USD","LU0348825331.USD","LU1497733557.USD","01600","BK1258","BK1504","BK1609","03800","LU0348735423.USD","06609","02525","LU2106854487.HKD","LU0315179316.USD","06862","IE00BZ08YR35.GBP","LU1917777945.USD","09878","LU0254981946.USD","LU0828237510.HKD","BK1598","BK1588","06996","BK1591","LU0594300179.USD","LU2357125470.USD","SG9999002562.SGD","SG9999015952.SGD","BK1195","IE0003851619.USD","LU0588545730.USD","LU1675838814.USD","06963","02509","06613","LU0856984785.SGD","BK1169","BK1618","BK1147","SG9999002828.SGD","BK1518","03681","LU0370786039.SGD","SG9999001051.SGD","LNVGY","LU1634259391.SGD","BK1142","06683","BK1164","IE00BVYPNP33.GBP","BK1219","01877","IE00B5MMRT66.SGD","LU0259732245.USD","LU0791591158.USD","BK1119","BK1540","LU1981816686.USD","HYDD.SI","01211","BK1222","BK1575","LU0072462343.USD","LU0449509016.USD","LU0084288322.USD","BK1128","IE00BZ08YS42.EUR","02886","LU1508157978.USD","09955","BK1595","LU0456827905.SGD","LU2543165471.USD","BK1184","LU1939255532.USD","LU1366334651.USD","09923","LU0823426308.USD","IE00BQXX3F31.USD","06919","LU2506951792.HKD","SGXZ62798434.SGD","00267","02105","IE0008368742.USD","BK1592","BK1227","BK1615","09877","09660","LU0307460666.USD","02431","BK1597","BK1144","LU0051755006.USD","03836","LU2097828631.EUR","01276","01117","LU0605514214.HKD","02598","06677","09959","LU0417516571.SGD","LU1328277881.USD","LU2778985437.USD","LU0348784397.USD","IE00BZ08YT58.USD","01405","LU1211504680.USD","02018","BK1228","LU2328871848.SGD","IE00B031J352.USD","01809","01681","02155","BK1212","LU0831093199.SGD","01735","06168","LU1166156734.SGD","LU2663582299.SGD","BK1175","06086","03680","LU0164880469.USD","BK1522","00861","02273","02150","00363","LU2097828714.EUR","BK1209","02420","00699","LU0048575426.USD","BK1548","BK1111","LU0214875030.USD","00300","06855","02177","LU1242518857.USD","LU2360107325.USD","LU1807302812.USD","BK1100","LU0327786744.USD","LU0819121731.USD","06069","01651","IE00BPRC5H50.USD","LU0702159699.USD","00867","02460","BK1224","02197","LU0823414551.USD","BK1158","LU0593848301.USD","LU0501845795.SGD","00512","09919","06058","LU0531971595.HKD","SG9999006597.SGD","00460","BK1110","LU2097828805.USD","BK1141","03738","LU1226287875.USD","BK1143","LU1956131251.USD","LU0289961442.SGD","BK1126","LU0823039010.USD","01783","02889","LU0541502299.USD","LU0348766576.USD","02121","06160","HK0000320223.HKD","LU1770034418.SGD","SG9999014674.SGD","BK1247","82331","BK1215","BK1198","LU0049112450.USD","BK1607","LU1960683339.HKD","LU0043850808.USD","06186","LU0231483743.USD","BK1104","BK1579","06633","LU0244354667.USD","09678","00656","LU0880133367.SGD","02453","LU1224709979.USD","LU0449515922.USD","BK1590","LU1328615791.USD","01952","02595","IE00B8HQ1Z84.USD","LU0469268626.HKD","LU1719994722.HKD","LU0509642566.USD","LU0488056044.USD","01384","LU0516422366.SGD","LU2023250504.SGD","BK1150","BK1559","HK0000252160.HKD","LU1366334578.USD","SG9999015978.USD","02533","BK1190","BK1127","LU0463099449.HKD","02556","02567","01070","LU0052756011.USD","LU2348774022.SGD","02057","002594","06913","BK1515","LU0588546209.SGD","00875","LU1770036033.HKD","01378","LU1303224171.USD","LU2125910500.SGD","09961","LU0620787316.HKD","IE0008369823.USD","LU1226287792.SGD","LU1267930227.SGD","LU0516422440.USD","BK1170","LU0979878070.USD","BK1613","LU0348767384.USD","BK1586","LU0594300419.USD","02157","BK1161","81211","BK1509","BK1531","BK1520","LU0868486357.SGD","SG9999001226.SGD","02158","BK1544","LU0762540952.USD","01939","BK1240","SG9999002463.SGD","LU0708995583.HKD","SG9999003461.SGD","LU0211977185.USD","SGXZ86797644.SGD","IE0031814852.USD","01773","LU1282649810.SGD","LU0345776255.USD","BK1555","LU3063872942.SGD","00777","01880","BK1167","LU0329678170.USD","BK1556","09992","LU1497733631.SGD","LU0289739343.SGD","IE00BMCWC346.EUR","82020","BK1225","LU0329678337.USD","BK1608","BK1154","BK1516","02469","BK1550","LU0348805143.USD","LU0287142896.SGD","09890","02419","02380","LU0737861699.HKD","09911","86618","BK1530","BK1253","LU0634319403.HKD","LU0261950470.USD","02020","LU0264606111.USD","LU0823397285.USD","80020","SG9999006514.SGD","BK1188","SG9999000459.SGD","LU1522347837.USD","BK1136","LU0048597586.USD","02190","09880","02436","01471","LU1235295612.USD","02565","BK1610","09996","BK1194","LU0314109678.HKD","LU1226288253.USD","LU2177674079.SGD","00017","LU1023057109.AUD","02858","03658","BK1577","LU0819123356.HKD","LU1102505929.USD","BK1528","LU0289960550.SGD","LU1880383366.USD","LU0054450605.USD","BK1553","LU1634259557.SGD","06060","03939","LU1720050803.USD","BK1140","LU0499858438.USD","09990","BK1557","IE00B543WZ88.USD","LU0511384066.AUD","LU2399975544.HKD","BK1502","BK1257","BK1096","03709","02298","LU0143863198.USD","00999","BK1095","01640","02511","BK1229","01818","HK0000320264.USD","01448","LU0572944931.SGD","LU2249611893.SGD","02411","00384","BK1125","BK1587","LU0531970944.HKD","06657","IE0032431581.USD","LU1880383440.USD","BK1523","LU0791590937.USD","02400","IE0003795394.USD","LU0572940350.SGD","LU1974910355.USD","SG9999001903.USD","SGXZ90724238.SGD","BK1593","BK1574","BK1233","IE00B8L5B284.USD","03145","LU1039395188.USD","BK1179","LU1048588211.SGD","02506","00020","LU1868837565.USD","LU0143863784.USD","00135","BK1183","SG9999000418.SGD","02331","LU2097828557.USD","02498","01177","BK1526","LU2097828474.EUR","IE00BGHQDM52.EUR","BK1139","LU1861214812.USD","01585","LU0456846285.SGD","LU2153592121.USD","BK1137","LU1813983027.USD","SG9999002950.SGD","LU0540923850.HKD","BK1594","02590","BK1519","02392","LU0384037296.USD","LU0320764599.SGD","01739","LU0348827113.USD","LU0164872284.USD","LU1481107354.HKD","LU0082770016.USD","01318","02382","LU0229945570.USD","LU2153591404.USD","00826","LU2476274720.SGD","LU0359201885.HKD","02451","00305","LU0310800965.SGD","06090","LU0611395673.USD","02627","00451","LU0251143458.SGD","HK0000252152.HKD","09639","02171","BK1220","00136","LU1993786604.SGD","BK1193","BK1117","LU2460026573.USD","BK1500","LU0140636845.USD","BK1216","02551","LU0417516738.SGD","LU0737861772.HKD","LU1242518931.SGD","01762","01907","09985","LU0274383008.USD","LU0499858602.USD","03650","BK1171","LU1861219969.SGD","LU1046422090.SGD","01911","LU0516423174.USD","09699","LU0823397103.USD","LU0048580855.USD","02145","BK1541","LU0823038988.USD","LU0502904849.HKD","02013","BK1114","SG9999011746.SGD","LU0588545490.SGD","BK1148","LU0871576103.HKD","LU0823426480.USD","LU0269904917.USD","LU2045819591.USD","LU0261947096.USD","BK1589","BK1214","BK1619","BK1168","LU0455707207.USD","LU0165289439.USD","LU0572939691.SGD","HK0000306685.HKD","01093","BK1512","02167","ANPDY","LU1226288170.HKD","BK1116","LU1152091168.USD","LU0011963245.USD","LU0107464264.USD","BK1131","00382","LU0149721374.USD","02616","LU1282649067.USD","IE00B031HY20.USD","02488","LU0828238088.HKD","09927","LU2008162690.USD","BK1582","LU0588545904.SGD","02096","BK1235","LU1102505762.USD","BK1207","IE00B29SXG58.USD","BK1564","02276","01969","LU1188198961.HKD","LU0359202008.SGD","BK1109","BK1605","BK1189","LU0541501648.USD","LU0359201612.USD","01530","02650","02587","01458","BK1191","BK1596","BK1554","LU0348783233.USD","02670","IE00BGV7N243.SGD","LU2449936058.SGD","IE0034224299.USD","SG9999004311.SGD","IE00BD6J9T35.USD","LU1831875114.USD","01440","BYDDY","LU2242644610.SGD","LNNGY","BK1237","BK1132","BK1524","06138","LU0516422952.EUR","LU2298064838.USD","02228","SG9999015986.USD","LU0640798160.USD","SG9999001069.SGD","LU0128525689.USD","BK1549","BK1178","BK1552","BK1578","LU0823437842.USD","LU2506952253.HKD","LU1152091754.HKD","LU0650527681.SGD","00992","HK0000165453.HKD","LU0039217434.USD","LU2488822045.USD","00884","LU0164939612.USD","BK1200","09690","BK1221","BK1616","02256","02315","IE00B0169L03.USD","LU0823414478.USD","LU0315178854.USD","00666","BK1521","IE00BQXX3C00.GBP","LU1951186391.HKD","BK1542","02279","06618","02696","BK1585","01833","LU0054237671.USD","09926","BK1239","BK1600","LU1226287529.USD","LU0052750758.USD","HK0000500386.USD","LU0082770016.SGD","LU1868838027.USD","09860","LU1497734951.SGD","06608","80992","LU0561508036.HKD","LU0431992006.USD","09636","BK1155","LU0072913022.USD","BK1230","BK1197","HK0000306701.USD","02100","BK1160","BK1604","LU0251144936.SGD","01119","IE00BQXX3D17.EUR","00302","LU0228659784.USD","BK1617","09956","LU2238339852.HKD","01519","LU2039709279.SGD","BK1186","03677","LU0345775950.USD","00960","SG9999000475.SGD","IE00BYV24P56.USD","LU0067412154.USD","LU1961090484.USD","BK1566","00798","02552","01520","BK1539","06821","BK1560","00855","BK1606","00003","LU0164865239.USD","BK1151","LU1794554557.SGD","LU0261950983.USD","LU2348773727.SGD","SG9999004220.SGD","BK1571","IE00BVYPNQ40.USD","LU1115378108.SGD","IE0009570106.USD","02250","LU2424517915.HKD","BK1124","LU0505663152.USD","LU1008478684.HKD","LU1868837722.USD","02268","LU1808992512.USD","03896","LU2294711713.HKD","LU0173614495.USD","LU0516423091.SGD","BK1527","LU1969619763.USD","LU0326950275.SGD","IE00B0JY6N72.USD","06100","LU0865486749.SGD","SG9999015945.SGD","LU2476274308.USD","03998","02629","03396","02142","01164","BK1163","BK1583","06988","LU0417516902.SGD","LU0543330566.HKD","LU1251922891.USD","BK1134","SG9999001093.SGD","01333"],"gpt_icon":1},{"id":"1159816616","title":"Lepu Biopharma (2157) Announces Proxy Arrangements for 2025 Second EGM","url":"https://stock-news.laohu8.com/highlight/detail?id=1159816616","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159816616?lang=en_us&edition=fundamental","pubTime":"2025-11-28 20:05","pubTimestamp":1764331504,"startTime":"0","endTime":"0","summary":"Lepu Biopharma Co., Ltd. (Stock Code: 2157) has released a proxy form in preparation for its 2025 second extraordinary general meeting (EGM), scheduled on December 18, 2025, at 10:30 a.m., at...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02157"],"gpt_icon":0},{"id":"1138630594","title":"Lepu Biopharma (2157) Proposes New RSU Scheme and Sets Date for Second 2025 EGM","url":"https://stock-news.laohu8.com/highlight/detail?id=1138630594","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138630594?lang=en_us&edition=fundamental","pubTime":"2025-11-28 20:02","pubTimestamp":1764331369,"startTime":"0","endTime":"0","summary":"Lepu Biopharma Co., Ltd. (Stock Code: 2157) has issued a circular announcing its Second 2025 Extraordinary General Meeting (EGM) to be held on December 18, 2025, at 10:30 a.m. in Beijing....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02157"],"gpt_icon":0},{"id":"2586781825","title":"Lepu Biopharma Co. Ltd. Announces Date for Second 2025 EGM Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2586781825","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586781825?lang=en_us&edition=fundamental","pubTime":"2025-11-28 19:43","pubTimestamp":1764330225,"startTime":"0","endTime":"0","summary":"Lepu Biopharma Co. Ltd. has announced that it will hold its Second 2025 Extraordinary General Meeting  on December 18, 2025, in Beijing. During the meeting, shareholders will consider and vote on the proposed adoption of the Restricted Share Unit Scheme .Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lepu Biopharma Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on November 28, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nNDL7LYYzv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02157"],"gpt_icon":0},{"id":"1186478247","title":"LEPU BIO-B (02157) Enters into CDMO Service Framework Agreement with Lepu Medical","url":"https://stock-news.laohu8.com/highlight/detail?id=1186478247","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186478247?lang=en_us&edition=fundamental","pubTime":"2025-11-28 16:50","pubTimestamp":1764319813,"startTime":"0","endTime":"0","summary":"LEPU BIO-B (02157) announced on November 28, 2025, that the company has signed a CDMO service framework agreement with Lepu Medical Technology (Beijing) Co., Ltd. Under the agreement, LEPU BIO-B...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0113","300003","BK0196","BK0028","BK0114","CDMO","BK4139","BK0201","02157","BK0042","BK0188","BK1161","BK0251"],"gpt_icon":0},{"id":"1124955979","title":"Lepu Biopharma (2157) Announces New Procurement Framework Agreement with Lepu Medical (300003)","url":"https://stock-news.laohu8.com/highlight/detail?id=1124955979","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124955979?lang=en_us&edition=fundamental","pubTime":"2025-11-28 16:43","pubTimestamp":1764319433,"startTime":"0","endTime":"0","summary":"Lepu Biopharma Co., Ltd. (2157) announced the signing of a new procurement framework agreement with Lepu Medical (300003), effective from January 1, 2026 to December 31, 2026. This follows the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02157"],"gpt_icon":0},{"id":"1179033970","title":"Lepu Biopharma (2157) Announces Continuing Connected Transaction with Lepu Medical","url":"https://stock-news.laohu8.com/highlight/detail?id=1179033970","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179033970?lang=en_us&edition=fundamental","pubTime":"2025-11-28 16:43","pubTimestamp":1764319421,"startTime":"0","endTime":"0","summary":"Lepu Biopharma Co., Ltd. (stock code: 2157) has entered into a CDMO Services Framework Agreement with Lepu Medical on November 28, 2025. Under this agreement, Lepu Biopharma will provide contract...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02157"],"gpt_icon":0},{"id":"2586026802","title":"Lepu Biopharma Signs New Procurement Framework Agreement with Lepu Medical","url":"https://stock-news.laohu8.com/highlight/detail?id=2586026802","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586026802?lang=en_us&edition=fundamental","pubTime":"2025-11-28 16:33","pubTimestamp":1764318798,"startTime":"0","endTime":"0","summary":"Lepu Biopharma Co. Ltd. announced the signing of a New Procurement Framework Agreement with Lepu Medical on November 28, 2025. The agreement covers the procurement of various goods and services for the period from January 1, 2026, to December 31, 2026. The company stated that the arrangement is expected to provide cost and operational efficiencies compared to sourcing from independent third parties. The transactions under this agreement were reviewed and approved by the company's board of directors, including independent non-executive directors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lepu Biopharma Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Ho","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nNDLkF9Cv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0042","BK0028","BK0113","BK0188","02157","BK0201","BK0251","BK0196","300003","BK1161","BK0114"],"gpt_icon":0},{"id":"2585143697","title":"MEIYOUHENG Wins NMPA Approval as World’s First EGFR-Targeting ADC from TOT BIOPHARM, BioDlink, and Lepu Biopharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2585143697","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585143697?lang=en_us&edition=fundamental","pubTime":"2025-11-21 21:00","pubTimestamp":1763730040,"startTime":"0","endTime":"0","summary":"TOT BIOPHARM International Co. Ltd., in partnership with BioDlink and Lepu Biopharma, has announced the successful regulatory approval and launch of MEIYOUHENG, the world's first EGFR-targeting ADC drug. The product received marketing approval from China's National Medical Products Administration  on October 30, 2025. This milestone marks the first time an antibody-drug conjugate  fully manufactured by a contract development and manufacturing organization  has reached the market in China, highlighting significant progress in the region's biopharmaceutical sector. The achievement underscores the robust collaboration and operational excellence among the involved organizations throughout the development, technology transfer, and manufacturing process.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should n","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nNDL4PbFd0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02157","BK1161","01875"],"gpt_icon":0},{"id":"1117424956","title":"Riding the Hong Kong Stock Rally: Bull Market Dawns in the East 2026 – 10th Zhitong Finance Capital Markets Annual Conference Invites You to a Capital Feast","url":"https://stock-news.laohu8.com/highlight/detail?id=1117424956","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117424956?lang=en_us&edition=fundamental","pubTime":"2025-11-18 08:56","pubTimestamp":1763427395,"startTime":"0","endTime":"0","summary":"As the fourth technological revolution sweeps across the globe, with AI and large model technologies reaching critical breakthroughs, capital engines are driving the revaluation of Chinese assets at...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00699","00290","06682","09678","02561","LU1808992512.USD","00552","02411","BK1194","BK1583","06660","BK1209","BK1608","LU1497734951.SGD","02279","BK1216","BK1593","LU1522347837.USD","LU2488822045.USD","06608","LU0348766576.USD","BK1175","00305","02268","BK1207","BK1148","02670","06090","BK1539","BK1219","BK1144","01681","02167","BK1095","IE00BYV24P56.USD","06919","BK1596","BK1124","HK0000500386.USD","IE00BVYPNP33.GBP","02886","SG9999002950.SGD","SG9999004220.SGD","00382","06069","01809","BK1531","BK1618","BK1518","BK1228","BK1114","LU0348767384.USD","02533","01651","BK1506","BK1579","00867","BK1613","BK1131","IE00B543WZ88.USD","BK1100","BK1591","HK0000252160.HKD","SG9999015945.SGD","00826","BK1224","BK1139","LU2460026573.USD","BK1530","02380","02105","BK1137","03658","BK1230","06677","02142","IE00BGHQDM52.EUR","SG9999003461.SGD","02096","BK1552","SG9999014674.SGD","02171","BK1529","BK1595","BK1104","BK1150","BK1500","LU2476274720.SGD","BK1587","02177","02511","02587","BK1155","BK1147","06100","BK1116","BK1582","SG9999015986.USD","02551","BK1542","BK1556","LU1497733631.SGD","01969","LU2476274308.USD","00196","BK1110","LU1634259557.SGD","BK1586","BK1592","09996","BK1578","00302","01318","09959","03145","BK1524","01783","02488","02858","BK1109","02256","IE00BMCWC346.EUR","BK1132","BK1619","00604","02157","02616","BK1521","HK0000252152.HKD","BK1606","02627","LU2778985437.USD","01228","02509","BK1527","BK1585","00855","BK1577","BK1193","00861","09919","01762","02431","09911","LU1634259391.SGD","BK1191","02453","SG9999015952.SGD","BK1225","01333","03738","SG9999001069.SGD","LU0348825331.USD","BK1183","BK1229","BK1178","LU0417516902.SGD","BK1221","06609","BK1141","01907","BK1186","LU1497733557.USD","00363","BK1142","BK1188","IE00B5MMRT66.SGD","01773","BK1575","BK1161","BK1258","BK1594","02420","IE00BPRC5H50.USD","IE00BVYPNQ40.USD","SG9999015978.USD","03315","02567","09878","BK1555","06633","BK1140","BK1609","00003","01167","BK1202","06996","BK1125","BK1171","BK1574","BK1163","BK1516","09860","01164"],"gpt_icon":0},{"id":"2582314387","title":"Lepu Biopharma (SEHK:2157): Valuation in Focus After Landmark EGFR-Targeted ADC Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2582314387","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582314387?lang=en_us&edition=fundamental","pubTime":"2025-11-12 08:33","pubTimestamp":1762907618,"startTime":"0","endTime":"0","summary":"Lepu Biopharma (SEHK:2157) just received conditional marketing approval from China's National Medical Products Administration for an innovative EGFR-targeted antibody-drug conjugate to treat recurrent or metastatic nasopharyngeal carcinoma. This milestone is expected to generate global attention and increased investor interest.\nSee our latest analysis for Lepu Biopharma.\nLepu Biopharma’s momentum has certainly kept investors on their toes this year. After surging to a 148% year-to-date share...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2157/lepu-biopharma-shares/news/lepu-biopharma-sehk2157-valuation-in-focus-after-landmark-eg","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2157/lepu-biopharma-shares/news/lepu-biopharma-sehk2157-valuation-in-focus-after-landmark-eg","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4231","BK1161","ADC","BK4211","LARK","BK4080","02157"],"gpt_icon":0},{"id":"1111428562","title":"HK Stock Connect Shareholding Changes | Nov 11","url":"https://stock-news.laohu8.com/highlight/detail?id=1111428562","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111428562?lang=en_us&edition=fundamental","pubTime":"2025-11-11 08:38","pubTimestamp":1762821515,"startTime":"0","endTime":"0","summary":"According to disclosed data on November 10, 2025, Hao Tian International Construction (01341), Sinohytec (02402), and Tianli International Holdings (01773) recorded the largest increases in Stock...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00826","00358","02828","LU0348825331.USD","02465","BK1119","BK1170","BK1151","00696","02865","06616","02432","SG9999006597.SGD","06613","BK1597","BK1169","00187","BK1225","BK1503","HK0000252152.HKD","BK1511","BK1596","HK0000500386.USD","BK1515","09885","02157","BK1202","BK1506","IE0034224299.USD","00525","BK1500","BK1575","BK1556","IE00BZ08YT58.USD","BK1138","BK1228","03800","LU1720050803.USD","03866","BK1147","BK1237","BK1235","BK1513","02208","BK1129","BK1161","BK1583","BK1205","09868","BK1568","BK1564","09606","02402","00874","BK1125","06178","01385","00991","BK1567","01072","BK1546","IE00BZ08YR35.GBP","BK1166","02837","01341","BK1505","LU0307460666.USD","02068","LU2213484517.USD","01951","00553","00189","03759","BK1197","BK1224","BK1587","BK1607","LU0588546209.SGD","BK1163","BK1558","BK1116","LU0417516738.SGD","BK1539","IE00BZ08YS42.EUR","02050","BK1141","06936","BK1526","BK1589","02338","BK1236","01709","BK1554","06869","BK1522","LU0320764599.SGD","02648","LU1808992512.USD","LU0405327494.USD","BK1592","01282","BK1183","BK1614","00568","BK1588","LU2543165471.USD","MCHmain","LU0593848301.USD","BK1149","LU0348735423.USD","00763","02800","02600","SG9999014674.SGD","BK1191","BK1148","BK1523","BK1126","BK1110","02587","BK1171","BK1610","LU1794554557.SGD","BK1164","BK1530","BK1175","02273","BK1521","LU0052750758.USD","BK1594","SG9999003461.SGD","BK1606","01071","BK1206","BK1576","BK1219","LU0708995583.HKD","01880","02255","06680","01347","LU0405327148.USD","02727","BK1529","06865","01773","HK0000252160.HKD","02533","BK1241","BK1560","00956","LU0417516902.SGD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.lepubiopharma.com","stockEarnings":[{"period":"1week","weight":-0.0362},{"period":"1month","weight":-0.0869},{"period":"3month","weight":-0.2056},{"period":"6month","weight":-0.4793},{"period":"1year","weight":0.1328},{"period":"ytd","weight":-0.0905}],"compareEarnings":[{"period":"1week","weight":0.0082},{"period":"1month","weight":-0.043},{"period":"3month","weight":0.0298},{"period":"6month","weight":0.0619},{"period":"1year","weight":0.1228},{"period":"ytd","weight":0.039}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Lepu Biopharma Co Ltd is a company principally engaged in the sales of pharmaceutical products and the research and development of new drugs. The Company is focused on oncology therapeutics, in particular, targeted therapy and oncology immunotherapy. The Company is dedicated to developing innovative antibody-drug conjugate (ADC) through an ADC technology development platform. The Company’s clinical-stage drug candidates cover targeted therapeutics and an immunotherapeutic, including MRG003, MRG002, CMG901, MRG004A, CG0070, MRG006A, MRG007, and CTM012.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.070458},{"month":2,"riseRate":0.5,"avgChangeRate":0.087235},{"month":3,"riseRate":0.25,"avgChangeRate":-0.056625},{"month":4,"riseRate":1,"avgChangeRate":0.229349},{"month":5,"riseRate":0.5,"avgChangeRate":-0.007459},{"month":6,"riseRate":0.5,"avgChangeRate":-0.04556},{"month":7,"riseRate":0.5,"avgChangeRate":0.067498},{"month":8,"riseRate":0.5,"avgChangeRate":-0.002458},{"month":9,"riseRate":0.5,"avgChangeRate":0.085192},{"month":10,"riseRate":0.25,"avgChangeRate":-0.14162},{"month":11,"riseRate":0.25,"avgChangeRate":0.007333},{"month":12,"riseRate":0.25,"avgChangeRate":-0.05091}],"exchange":"SEHK","name":"LEPU BIO-B","nameEN":"LEPU BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"LEPU BIO-B(02157),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest LEPU BIO-B(02157) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"LEPU BIO-B,02157,LEPU BIO-B股票,LEPU BIO-B股票老虎,LEPU BIO-B股票老虎国际,LEPU BIO-B行情,LEPU BIO-B股票行情,LEPU BIO-B股价,LEPU BIO-B股市,LEPU BIO-B股票价格,LEPU BIO-B股票交易,LEPU BIO-B股票购买,LEPU BIO-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LEPU BIO-B(02157),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest LEPU BIO-B(02157) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}